Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
08/2009
08/19/2009EP1233987B1 Immobilized single domain antigen-binding molecules
08/19/2009EP1194167B1 Immunotherapy of autoimmune disorders using antibodies which target b-cells
08/19/2009EP1187918B9 Tek antagonists
08/19/2009EP1131424B1 Mutation of the parkin gene, compositions, methods and uses
08/19/2009EP1078003B1 Plasmin inhibitors from the australian brown snake, pseudonaja textilis textilis
08/19/2009EP0971740B1 Fibronectin binding protein derived peptides which do not bind to fibronectin, antibodies thereto, and therapeutic uses
08/19/2009EP0942987B1 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes
08/19/2009CN101512007A Methods and compositions for use in treatment of patients with autoantibody positive diseases
08/19/2009CN101512004A Microbial synthesis of D-1,2,4-butanetriol
08/19/2009CN101511871A Anti-myostatin antibodies
08/19/2009CN101511870A Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor
08/19/2009CN101511869A Anti-MCP-1 antibodies, compositions, methods and uses
08/19/2009CN101511866A Modified human plasma polypeptide or Fc scaffolds and their uses
08/19/2009CN101511387A Arginine wash in protein purification using affinity chromatography
08/19/2009CN101509031A Method for preparing short and naked dinoflagellate toxin monoclone antibody
08/19/2009CN101509003A Sequence of enterovirns type71 genome and uses thereof
08/19/2009CN101508734A Anti-CD40 monoclonal antibody
08/19/2009CN101508733A Human avian influenza specific immunity globulin and preparation thereof
08/19/2009CN101508723A Polypeptide for preparing polyclonal antibody and uses thereof
08/19/2009CN100529076C Mammalian cytokines, related reagents and methods
08/19/2009CN100529075C Antihuman telomere enzyme reverse transcriptase single-chain antibody
08/19/2009CN100529074C Therapeutic binding molecules
08/19/2009CN100528229C Method of inhibiting tumor growth with anti-tissue factor antibodies
08/19/2009CN100528228C Escape mutants of newcastle disease virus as marker vaccines
08/18/2009US7576258 Transgenic transchromosomal rodents for making human antibodies
08/18/2009US7576194 Nucleotide sequences coding bacterial cell surface proteins for use in generating monoclonal antibodies for prevention and treatment of infection; for immunodiagnosis and immunoprophylaxis
08/18/2009US7576193 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation
08/18/2009US7576190 Fibroblast growth factor 21 compounds fused to proteins that have the effect of extending the in vivo half-life of the polypeptides; these fusion proteins can be used to treat non-insulin dependent diabetes mellitus, obesity and metabolic syndrome
08/18/2009US7576189 antibodies against such VEGFs, which may be used to inhibit their action, for example, to inhibit the growth of tumors, to treat diabetic retinopathy, rheumatoid arthritis and psoriasis
08/18/2009US7576187 Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof
08/18/2009US7576186 Composition of matter for delivering and/or affixing a stem cell to a target tissue comprising a first moiety that specifically binds to the stem cell surface operably affixed to a second moiety that specifically binds to the surface of a cell in the tissue
08/18/2009US7576185 PRO34128 antibodies
08/18/2009US7576184 Monoclonal antibody for use in detection of plant protein associated with natural rubber; diagnosing latex allergies and hypersensitivity
08/18/2009US7576182 Compositions and methods for the treatment of immune related diseases
08/18/2009US7576179 Moraxella catarrhalis outer membrane protein-106 polypeptide, gene sequence and uses thereof
08/18/2009US7576178 DADD, death activator death domain protein
08/18/2009US7576176 Neisseria meningitidis antigens and compositions
08/18/2009US7575938 Method for diagnosing liver diseases
08/18/2009US7575929 Diagnosis of multiple sclerosis with diketopiperazines
08/18/2009US7575923 CD19xCD3 specific polypeptides and uses thereof
08/18/2009US7575922 Polypeptide and gene encoding the same
08/18/2009US7575893 Producing high yield of monoclonal antibody in culture; for use in treatment of cell proliferative, inflammatory and nervous system disorders; immunoassay
08/18/2009US7575885 Tyrosylprotein sulfotransferases and methods of use thereof
08/18/2009US7575880 Method of screening an antibody for activity in clearing an amyloid deposit
08/18/2009US7575879 Bone morpogenic proteins; endothelial growth factor e (vegfe); wound healing agents; bradycardial agents; identification and preparation of vascular endothelial growth factor-E (VEGF-E), a novel polypeptide related to vascular endothelial growth factor (VEGF) and bone morphogenetic protein 1
08/18/2009US7575878 Methods of inhibiting leptin-induced signaling with fibronectin III domain antibodies
08/18/2009US7575876 Biomarkers for neurodegenerative disorders
08/18/2009US7575873 human monoclonal antibody fragment (Fab), cloned by phage display that binds specifically to oxidized forms of low density lipoproteins (OxLDL) and not native LDL; use of the antibody for methods of diagnosis and treatment of atherosclerosis
08/18/2009US7575872 An antibody specific for von Willebrand factor specific cleaving enzyme (hereinafter also referred to as ADAMTS-13), which can be obtained from a warm-blooded animal immunized and sensitized with a polypeptide containing a part or the whole of ADAMTS-13 amino acid sequence
08/18/2009US7575753 Relates to a kit for detecting and distinguishing one or more small round structure viruses (hereinafter called "SRSVs") in a specimen; SRSV detection kit comprising all antibodies against SRSV-related virus constituting peptides; human viral gastroenteritis
08/18/2009US7575749 Serpentine transmembrane antigens expressed in human cancers and uses thereof
08/18/2009US7575747 Antibodies, or fragments thereof, that are humanized variants of murine antibody 266 which employ complementarity determining regions derived from murine antibody 266; useful for treatment or prevention of conditions associated with A beta, including Alzheimer's disease, Down's syndrome
08/18/2009US7575746 anticarcinogenic; antibody or antigen-binding portion that specifically binds to human insulin-like growth factor I receptor; comprises: light and heavy chain region with frameworks mutations reverted back to amino acid sequence encoded by germ line A30 and DP35 genes; genetic engineering
08/18/2009US7575745 Ligand for herpes simplex virus entry mediator and methods of use
08/18/2009US7575742 Method of treating autoimmune diseases with interferon-beta and IL-2R antagonist
08/18/2009US7575741 Using interleukin-23 modulators to enhance wound healing
08/18/2009CA2413156C Expression vectors
08/18/2009CA2328805C Enzyme-protein complex
08/18/2009CA2230240C Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
08/18/2009CA2165203C Immunoglobulin g concentrate for therapeutic use and method for producing same
08/18/2009CA2105552C Soluble ligands for cd40
08/18/2009CA2054798C Hcv-specific peptides, agents therefor and the use thereof
08/13/2009WO2009100324A1 Engineered anti-tslpr antibodies
08/13/2009WO2009100318A1 1b20 pcsk9 antagonists
08/13/2009WO2009100297A1 1d05 pcsk9 antagonists
08/13/2009WO2009100194A2 Camptothecin-binding moiety conjugates
08/13/2009WO2009100140A1 Anti-clta-4 antibodies with reduced blocking of binding of ctla-4 to b7 and uses thereof
08/13/2009WO2009100110A1 Alpha 5 - beta 1 antibodies and their uses
08/13/2009WO2009100035A2 Interleukin-21 (il-21) and il-21 receptor (il-21r) modulation of regulatory t cells and forkhead box p3 (foxp3)
08/13/2009WO2009099961A2 Engineered antibody constant domain molecules
08/13/2009WO2009099829A1 Composition comprising antibody that binds to domain ii of her2 and acidic variants thereof
08/13/2009WO2009099728A1 Anti-cd79b antibodies and immunoconjugates and methods of use
08/13/2009WO2009099719A2 Compositions and methods for the treatment of tumor of hematopoietic origin
08/13/2009WO2009099561A2 Urinary ca125 peptides as biomarkers of ovarian cancer
08/13/2009WO2009099394A1 Binding protein and epitope-blocking elisa for the universal detection of h5-subtype influenza viruses
08/13/2009WO2009099204A1 Method and kit for detection of anti-avibacterium paragallinarum antibody
08/13/2009WO2009099176A1 Antibody capable of binding specifically to aβ-oligomer, and use thereof
08/13/2009WO2009099149A1 Anti-d-amino acid monoclonal antibody, and immunological analysis method for d-amino acid using anti-d-amino acid monoclonal antibody
08/13/2009WO2009098700A1 Siva 3, its preparation and use
08/13/2009WO2009098492A2 Modulation of adenoviral tropism
08/13/2009WO2009098290A1 Fto-modified non-human mammal
08/13/2009WO2009098238A1 Anti-trka antibodies and derivatives thereof
08/13/2009WO2009097704A1 Antigen-binding polypeptides against cartilage degeneration
08/13/2009WO2009079308A3 Composition and method of use of sheep fab phage display library
08/13/2009WO2009077993A3 Treatment of interstitial cystitis
08/13/2009WO2009062081A3 Methods and compositions for antibody or vaccine therapy
08/13/2009WO2009062051A3 Methods and compositions for antibody therapy
08/13/2009WO2009052209A3 Isolation of stem cells and effective control of contamination
08/13/2009WO2009036379A3 Rationally designed, synthetic antibody libraries and uses therefor
08/13/2009WO2007113685A8 USE OF THE α CHAIN OF BRAIN SPECTRIN AND FRAGMENTS THEREOF, FOR DIAGNOSING CEREBRAL DISEASES
08/13/2009US20090205061 Taste Receptors Of The T1R Family From Domestic Cat
08/13/2009US20090203887 Novel Centromeric Protein Shugoshin
08/13/2009US20090203886 Humanized anti cd20 monoclonal antibody
08/13/2009US20090203842 Macromolecular Conjugates And Processes For Preparing The Same
08/13/2009US20090203608 reducing lipid accumulation in an adipocyte; finding a therapeutic agents for treating obesity, diabetes, arteriosclerosis
08/13/2009US20090203598 Abc transporter ligand
08/13/2009US20090203596 Phosphatase Inhibitor Protein-1 As A Regulator of Cardiac Function
08/13/2009US20090203538 Method of classifying antibody, method of identifying antigen, method of obtaining antibody or antibody set, method of constructing antibody panel and antibody or antibody set and use of the same
08/13/2009US20090203124 Mage-a3 peptides presented by hla-dr1 molecules
08/13/2009US20090203122 Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, x-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof